Literature DB >> 20513739

Pulmonary resection for lung cancer patients on chronic hemodialysis: clinical outcome and long-term results after operation.

Makoto Takahama1, Ryoji Yamamoto, Ryu Nakajima, Takuma Tsukioka, Hirohito Tada.   

Abstract

The purpose of this study was to investigate the clinical characteristics of chronic hemodialysis (HD) patients with lung cancer who underwent pulmonary resection at the authors' hospital. Subjects were 24 chronic HD patients (1.1%) from among 2178 patients who underwent pulmonary resection for lung cancer at our hospital between December 1994 and March 2009. Subjects included 20 males (83.3%), and mean age was 65.9 years. Twenty-two patients underwent lobectomy, one underwent a wedge resection and one underwent a segmentectomy. Histological diagnoses included squamous cell carcinoma in 12 patients, adenocarcinoma in nine, small cell carcinoma in two and adenosquamous carcinoma in one. The distribution of pathological staging was IA in nine cases, IB in five, IIB in five, IIIA in three, and IIIB in two. There was no operative mortality, and the overall morbidity rate was 58.3%. Disease-free interval was six to 102 months with a median of 54 months, and the five-year survival rate was 43.0%. Cases of pulmonary resection for lung cancer in chronic HD patients were investigated. There were no operative deaths or deaths in hospital, but three patients had serious complications. These data indicate that surgery can be performed safely with appropriate HD and general management in the perioperative period.

Entities:  

Mesh:

Year:  2010        PMID: 20513739     DOI: 10.1510/icvts.2009.230003

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  8 in total

1.  Outcomes, safety, and feasibility of video-assisted thoracic surgery in lung cancer patients on hemodialysis: a case series.

Authors:  Yuji Otsuki; Hiroaki Kuwahara; Hirofumi Konn
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-10-09

2.  Video-assisted thoracoscopic lobectomy for non-small cell lung cancer: a morbidity limiting approach in a patient on chronic hemodialysis and double agent antiplatelet therapy.

Authors:  Guido Caroli; Giampiero Dolci; Andrea Dell'Amore; Nizar Asadi; Domenico Greco; Ammari Chadi; Alessandro Bini; Franco Stella
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-07-25

3.  Life-threatening complications after pulmonary resection for lung cancer in patients on chronic hemodialysis.

Authors:  Kenji Tomizawa; Katsuaki Sato; Shuta Ohara; Toshio Fujino; Takamasa Koga; Masaya Nishino; Yoshihisa Kobayashi; Masato Chiba; Masaki Shimoji; Kenichi Suda; Toshiki Takemoto; Tetsuya Mitsudomi
Journal:  Surg Today       Date:  2019-01-31       Impact factor: 2.549

4.  Frequency of multiple primary cancers in the lung and other organs in hemodialysis patients.

Authors:  Toshiro Obuchi; Takao Saito; Akinori Iwasaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-05-08

5.  Clearance and safety of the radiocontrast medium iopamidol in peritoneal dialysis patients.

Authors:  Shingo Hatakeyama; Akihiko Abe; Takehiro Suzuki; Yasuhiro Hashimoto; Takuya Koie; Tomihisa Funyu; Shigeru Satoh; Tomonori Habuchi; Chikara Ohyama; Shigeki Matsuo
Journal:  Int J Nephrol       Date:  2011-10-19

Review 6.  Recommendations for perioperative management of lung cancer patients with comorbidities.

Authors:  Hiroyoshi Tsubochi; Tomoki Shibano; Shunsuke Endo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-11-16

7.  Video-assisted thoracoscopic surgery after renal transplantation: A single-institution experience.

Authors:  Hideyuki Maeda; Masato Kanzaki; Kei Sakamoto; Takuma Kikkawa; Tamami Isaka; Kunihiro Oyama; Masahide Murasugi; Shohei Fuchinoue; Kazunari Tanabe; Takamasa Onuki
Journal:  Asian J Endosc Surg       Date:  2015-10-21

8.  Clinical Prognosis of Lung Cancer in Patients with Moderate Chronic Kidney Disease.

Authors:  Taehee Kim; Sang Hyuk Kim; Hayoung Choi; Tae Rim Shin; Hwan Il Kim; Seung Hun Jang; Ji Young Hong; Myung Goo Lee; Soojie Chung; In Gyu Hyun; Yun Su Sim
Journal:  Cancers (Basel)       Date:  2022-09-30       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.